JNJ Stock
Johnson & Johnson
—
Price
Daily closes via Alpaca (IEX); today's point is the latest trade.
Key stats
Valuation
P/E (trailing)40.7
Forward P/E23.7
Price / sales6.6
Price / book8.0
EPS (12 mo)$6.59
Dividend yield3.12%
Beta0.19
Financial health last 12 months
Revenue growth+7.8%
Earnings growth-36.4%
Gross margin67.7%
Net margin+16.2%
Return on equity19.6%
Debt / equity0.55
Hover a figure for what it means.
Analyst ratings Nov 2026 · 30 analysts
Consensus: Buy
Strong buy 7Buy 14
Hold 9Sell 0
Strong sell 0
| Month | Buy | Hold | Sell | Consensus |
|---|---|---|---|---|
| Nov 2026 | 21 | 9 | 0 | Buy |
| Oct 2026 | 22 | 8 | 0 | Buy |
| Sep 2026 | 22 | 9 | 0 | Buy |
| Aug 2026 | 22 | 9 | 0 | Buy |
Latest news
Sector Update: Healthcare Stocks Rise Late Afternoon
Yahoo · 1d ago
Sector Update: Healthcare Stocks Rise Friday Afternoon
Yahoo · 1d ago
Dividend Champion, Contender, And Challenger Highlights: Week Of November 22
SeekingAlpha · 1d ago
What Does Eli Lilly Offer That Merck Does Not?
Yahoo · 1d ago
J&J to install first Ottava robot in US hospital
Yahoo · 1d ago
Headlines from the last 10 days via Finnhub; links open the publisher's article.
Next earnings
No report scheduled in the next 4 months.
Past earnings moves
No tracked reports yet. TradeSphere saves the expected and actual move for every report from Nov 3, 2026 on, for stocks on the Earnings page.